Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 724022

Nanotherapeutics in the EU : an overview on current state and future directions


Hafner, Anita; Lovrić, Jasmina; Perina Lakoš, Gorana; Pepić, Ivan
Nanotherapeutics in the EU : an overview on current state and future directions // International journal of nanomedicine, 9 (2014), 1; 1005-1023 doi:10.2147/IJN.S55359 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 724022 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Nanotherapeutics in the EU : an overview on current state and future directions

Autori
Hafner, Anita ; Lovrić, Jasmina ; Perina Lakoš, Gorana ; Pepić, Ivan

Izvornik
International journal of nanomedicine (1176-9114) 9 (2014), 1; 1005-1023

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
nanotechnology ; drug delivery ; EU approval procedures ; EU marketed products

Sažetak
The application of nanotechnology in areas of drug delivery and therapy (ie, nanotherapeutics) is envisioned to have a great impact on public health. The ability of nanotherapeutics to provide targeted drug delivery, improve drug solubility, extend drug half- life, improve a drug’s therapeutic index, and reduce a drug’s immunogenicity has resulted in the potential to revolutionize the treatment of many diseases. In this paper, we review the liposome-, nanocrystal-, virosome-, polymer therapeutic-, nanoemulsion-, and nanoparticle-based approaches to nanotherapeutics, which represent the most successful and commercialized categories within the field of nanomedicine. We discuss the regulatory pathway and initiatives endeavoring to ensure the safe and timely clinical translation of emerging nanotherapeutics and realization of health care benefits. Emerging trends are expected to confirm that this nano-concept can exert a macro-impact on patient benefits, treatment options, and the EU economy.

Izvorni jezik
Engleski

Znanstvena područja
Farmacija



POVEZANOST RADA


Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb

Profili:

Avatar Url Ivan Pepić (autor)

Avatar Url Jasmina Lovrić (autor)

Avatar Url Anita Hafner (autor)

Poveznice na cjeloviti tekst rada:

doi dx.doi.org www.dovepress.com

Citiraj ovu publikaciju:

Hafner, Anita; Lovrić, Jasmina; Perina Lakoš, Gorana; Pepić, Ivan
Nanotherapeutics in the EU : an overview on current state and future directions // International journal of nanomedicine, 9 (2014), 1; 1005-1023 doi:10.2147/IJN.S55359 (međunarodna recenzija, članak, znanstveni)
Hafner, A., Lovrić, J., Perina Lakoš, G. & Pepić, I. (2014) Nanotherapeutics in the EU : an overview on current state and future directions. International journal of nanomedicine, 9 (1), 1005-1023 doi:10.2147/IJN.S55359.
@article{article, author = {Hafner, Anita and Lovri\'{c}, Jasmina and Perina Lako\v{s}, Gorana and Pepi\'{c}, Ivan}, year = {2014}, pages = {1005-1023}, DOI = {10.2147/IJN.S55359}, keywords = {nanotechnology, drug delivery, EU approval procedures, EU marketed products}, journal = {International journal of nanomedicine}, doi = {10.2147/IJN.S55359}, volume = {9}, number = {1}, issn = {1176-9114}, title = {Nanotherapeutics in the EU : an overview on current state and future directions}, keyword = {nanotechnology, drug delivery, EU approval procedures, EU marketed products} }
@article{article, author = {Hafner, Anita and Lovri\'{c}, Jasmina and Perina Lako\v{s}, Gorana and Pepi\'{c}, Ivan}, year = {2014}, pages = {1005-1023}, DOI = {10.2147/IJN.S55359}, keywords = {nanotechnology, drug delivery, EU approval procedures, EU marketed products}, journal = {International journal of nanomedicine}, doi = {10.2147/IJN.S55359}, volume = {9}, number = {1}, issn = {1176-9114}, title = {Nanotherapeutics in the EU : an overview on current state and future directions}, keyword = {nanotechnology, drug delivery, EU approval procedures, EU marketed products} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka::


  • PubMed


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font